News

  1. Landec Corporation Announces Intention To Become Lifecore Biomedical 8/10/2022

    Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – today formally announced the Company’s path forward as a CDMO-focused life sciences company, complete with a planned corporate rebranding, new ticker symbol, and the naming of its go-forward executive leadership team and Board of Directors

  2. Genixus Receives Federal Registration & State Licensing To Begin Production Of KinetiX™ Ready-To-Administer (RTA) Syringe Platform For Acute And Critical Care Medicines 8/3/2022

    Genixus, a pharmaceutical company focused on transforming acute and critical care medicines, today announced that it has received both federal registration and state licensing to begin commercial production of its new KinetiX™ RTA Platform brand of pre-filled syringes

  3. Evonik Now Offers Enteric Protected Ready To Fill Capsules EUDRACAP In IPEC GMP Quality 7/27/2022

    Evonik’s EUDRACAP enteric easy-to-handle capsules are now globally available produced under IPEC-GMP. Launched last year, EUDRACAP enteric are functional, ready-to-fill capsules that help pharmaceutical companies bring complex oral drug products to market faster

  4. Novavax Announces Expanded Agreement With SK Bioscience To Manufacture COVID-19 Vaccine Containing Omicron Variant And Manufacture The Novavax COVID-19 Vaccine In Prefilled Syringes 7/19/2022

    Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, has signed agreements with its partner, SK bioscience, for the manufacturing and supply of a version of the Novavax COVID-19 vaccine (NVX-CoV2373) containing Omicron variant and for the manufacture of the vaccine in prefilled syringes

  5. Piramal Pharma Solutions Holds Grand Opening Ceremony For New API Plant At Aurora, Canada Manufacturing Site 7/12/2022

    Piramal Pharma Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), held a Grand Opening to celebrate the official inauguration of a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario.

  6. Fill/Finish CMO Announces New Sterility Testing Isolator Technology For GMP Batches 6/28/2022

    Berkshire Sterile Manufacturing (BSM), a fill finish CMO located in Lee, MA, is proud to announce their sterility testing isolator is ready to perform onsite sterility testing for its GMP batches. The new service is expected to shorten the release for most, if not all the company’s clients.

  7. Kindeva Drug Delivery Announces Collaboration With Synopsys 6/15/2022

    Kindeva Drug Delivery (Kindeva) has announced a collaboration with Synopsys, Inc. involving the implementation of Synopsys Simpleware™ automated software solutions to assist in creating a state-of-the-art system for accurately measuring Kindeva’s microstructured transdermal system (MTS) arrays.

  8. West Introduces Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System At BIO International Convention 6/13/2022

    Daikyo Crystal Zenith® (CZ®) is a technologically advanced cyclic olefin polymer containment and delivery system that offers an alternative to glass, mitigating the risk of breakage and reducing the chance of particulates, contamination, and extractables.

  9. Societal CDMO Announces Key New Customer Project Within Automated Fill/Finish And Lyophilization Unit At San Diego Facility 6/8/2022

    Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced a key new customer project utilizing its automated fill/finish line and lyophilization unit at the company’s San Diego facility

  10. WuXi Biologics Launches First Commercial Drug Product Facility For Pre-Filled Syringes 6/5/2022

    WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility DP5 located in Wuxi, China.